Spring 2025
Preview: Legal, Tax + Accounting
IP, market studies, finance expertise: Companies need external expertise from consulting firms and commercial law firms. For biotech start-ups, IP rights and good legal advice are often the only assets they can use in deal negotiations with Big Pharma players to ensure that their clinical programmes can be advanced to the capital-intensive pivotal clinical stage and market authorisation.
Topics in this issue:
- Market studies
- Finance expertise
- Large transactions
- IP (Intellectual Property) rights and legal advice
- M&A (Mergers and Acquisitions)
- IPOs (Initial Public Offering)
Interested in advertising with us? We’re happy to advise you!
Christian Böhm
+49-30-264921-49
c.boehm@biocom
Oliver Schnell
+49-30-264921-45
o.schnell@biocom.de
Andreas Macht
+49-30-264921-54
a.macht@biocom.de